What are Myambutol (isoniazid/ethambutol) and Biaxin (clarithromycin)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 7, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

What are Myambutol and Biaxin?

Myambutol (ethambutol) is a first-line oral antituberculosis drug that specifically targets actively growing Mycobacterium tuberculosis, while Biaxin (clarithromycin) is a macrolide antibiotic used to treat various bacterial infections including nontuberculous mycobacterial (NTM) infections, respiratory tract infections, and as part of H. pylori eradication regimens. 1, 2

Myambutol (Ethambutol)

Primary Use: Ethambutol is a first-line agent for treating all forms of tuberculosis caused by susceptible organisms 3.

Key Clinical Role:

  • Included in initial TB treatment regimens primarily to prevent emergence of rifampin resistance when primary isoniazid resistance may be present 3
  • Part of standard 4-drug initial phase regimens (isoniazid, rifampin, pyrazinamide, ethambutol) for drug-susceptible pulmonary TB 3

Dosing:

  • Adults: 15-20 mg/kg daily or 50 mg/kg twice weekly 3
  • Children: 15-20 mg/kg daily (maximum 1.0 g) or 50 mg/kg twice weekly (maximum 2.5 g) 3

Critical Adverse Effect:

  • Retrobulbar neuritis causing decreased visual acuity or red-green color discrimination 3
  • Risk is dose-related with minimal risk at 15 mg/kg daily
  • Generally not recommended for young children (<5 years) whose visual acuity cannot be monitored, unless resistance to isoniazid or rifampin is suspected 3

Special Populations:

  • Safe in pregnancy 3
  • Requires dose adjustment in renal insufficiency (cleared primarily by kidneys) 3

Biaxin (Clarithromycin)

Primary Uses: Clarithromycin is a macrolide antibiotic with multiple indications 2:

For Adults:

  • Respiratory infections: pharyngitis/tonsillitis, sinusitis, acute bacterial exacerbation of chronic bronchitis, community-acquired pneumonia
  • Skin and skin structure infections
  • Disseminated Mycobacterium avium complex (MAC) infections
  • H. pylori eradication (in combination with amoxicillin and proton pump inhibitors)

For Nontuberculous Mycobacterial Disease:

  • Macrolides (clarithromycin or azithromycin) are the cornerstone of MAC pulmonary disease treatment 4
  • For noncavitary nodular/bronchiectatic MAC: 3 times weekly macrolide-based regimen suggested 4
  • For cavitary or severe MAC disease: daily macrolide-based regimen suggested 4
  • Treatment duration: at least 12 months after culture conversion 4

Key Advantage Over Erythromycin:

  • Better acid stability and bioavailability
  • Twice-daily dosing (vs. four times daily)
  • Lower gastrointestinal intolerance
  • Greater activity against selected organisms like H. influenzae 5

Critical Caveat for NTM Treatment:

  • The most important goal in MAC therapy is preventing macrolide resistance 4
  • Always use a 3-drug macrolide-containing regimen (not 2-drug) to prevent resistance development 4
  • For M. kansasii: clarithromycin can substitute for isoniazid in combination with rifampin and ethambutol 4

Drug Interactions:

  • Rifampin significantly reduces clarithromycin serum levels, which may impact efficacy 6

Resistance Concerns:

  • Clarithromycin-containing regimens should not be used in patients with known or suspected clarithromycin-resistant isolates 2
  • If treatment fails, susceptibility testing should be performed 2

Related Questions

What is the best recommendation for a patient with active tuberculosis (TB) being treated with rifampin (RIF), isoniazid (INH), pyrazinamide (PZA), and ethambutol (EMB) who wants to start pre-exposure prophylaxis (PrEP) for HIV prevention?
What is the recommended treatment regimen for a patient with active tuberculosis who is currently on ethambutol (ETH), isoniazid (INH), and rifampin (RIF)?
What are the potential side effects of Akurit 4 (rifampicin, isoniazid, pyrazinamide, ethambutol) to counsel a patient about?
What is the maximum dosage of Isoniazid (INH) for anti-tubercular treatment?
What is the most likely cause of discolored saliva in a patient with tuberculosis (TB) on standard multi-drug therapy, including Ethambutol, Isoniazid, Moxifloxacin, Pyrazinamide, and Rifampin?
In a patient taking lisinopril 40 mg and amlodipine, what is the best calcium‑channel blocker to add or substitute, considering a resting heart rate ≤60 bpm or significant conduction disease?
What is the appropriate evaluation and management of anhedonia in a patient with Parkinson disease?
What causes small‑fiber neuropathy in the feet and lower legs?
In a man over 50 with symptomatic benign prostatic hyperplasia who has failed maximal-dose tamsulosin (0.4 mg daily) for 4–6 weeks, what is the next step in management?
What is the mechanism of action, appropriate dosing regimen, and associated risks of using pramipexole to treat anhedonia in a patient with Parkinson disease?
Is it permissible under Medicare regulations to use EzPAP (positive expiratory pressure device), Acapella (oscillating positive expiratory pressure device), Cough Assist (mechanical insufflator‑exsufflator), and Therapy Vest (high‑frequency chest wall oscillation) as a blanket wellness program for skilled nursing facility and long‑term care patients without documented respiratory indications, or does this constitute fraudulent billing?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.